Skip to Content

SEC Filings

Filing date	Form	Description	View
Apr 22, 2021	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-21-126831.pdf 0001193125-21-126831.rtf 0001193125-21-126831.xls View HTML
Apr 16, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-016103.pdf 0000899243-21-016103.rtf 0000899243-21-016103.xls View HTML
Apr 15, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-015953.pdf 0000899243-21-015953.rtf 0000899243-21-015953.xls View HTML
Apr 14, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-015801.pdf 0000899243-21-015801.rtf 0000899243-21-015801.xls View HTML
Apr 14, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-015803.pdf 0000899243-21-015803.rtf 0000899243-21-015803.xls View HTML
Apr 12, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-015528.pdf 0000899243-21-015528.rtf 0000899243-21-015528.xls View HTML
Apr 09, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-015475.pdf 0000899243-21-015475.rtf 0000899243-21-015475.xls View HTML
Apr 01, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-014336.pdf 0000899243-21-014336.rtf 0000899243-21-014336.xls View HTML
Mar 26, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-013719.pdf 0000899243-21-013719.rtf 0000899243-21-013719.xls View HTML
Mar 25, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-013499.pdf 0000899243-21-013499.rtf 0000899243-21-013499.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2023 Merrimack Pharmaceuticals.